Table: Rohto -2025/26 parent results

Rohto Pharmaceutical

13/05/2026 07:34

May 13 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            140.84          136.56                                
                 (+3.1 pct)      (+5.9 pct)                              
  Operating         20.51           20.03                                
                 (+2.4 pct)      (-6.6 pct)                              
  Recurring         32.36           22.68                                
                 (+42.7 pct)     (-15.0 pct)                             
  Net               24.88           18.86                                
                 (+31.9 pct)     (-5.6 pct)                              
  EPS            110.12 yen       82.79 yen                              
  EPS Diluted    105.52 yen       82.38 yen                              
  Ann Div         46.00 yen       36.00 yen      50.00 yen               
  -Q2 Div         21.00 yen       16.00 yen      25.00 yen               
  -Q4 Div         25.00 yen       20.00 yen      25.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T